Information Journal Paper
APA:
Copy. (2018). Silymarin increases the sensitivity of breast cancer cells to doxorubicin in doxorubicin-induced MCF-7 cells by inhibiting breast cancer resistance protein expression. JOURNAL OF PHYSICS: CONFERENCE SERIES, 1073(3), 0-0. SID. https://sid.ir/paper/771330/en
Vancouver:
Copy. Silymarin increases the sensitivity of breast cancer cells to doxorubicin in doxorubicin-induced MCF-7 cells by inhibiting breast cancer resistance protein expression. JOURNAL OF PHYSICS: CONFERENCE SERIES[Internet]. 2018;1073(3):0-0. Available from: https://sid.ir/paper/771330/en
IEEE:
Copy, “Silymarin increases the sensitivity of breast cancer cells to doxorubicin in doxorubicin-induced MCF-7 cells by inhibiting breast cancer resistance protein expression,” JOURNAL OF PHYSICS: CONFERENCE SERIES, vol. 1073, no. 3, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/771330/en